Overview
An international scientific journal called Journal Neuroscience and Neuropharmacology publishes high-quality articles on a variety of topics, including molecular diseases, neuroendocrinology, neurotoxicology, intracellular inflammation, neurodegenerative diseases, sensory transduction, neural processing, and gene regulation and genetics.
The Journal of Neuroscience and Neuropharmacology welcomes submissions of the following article types: Review Article, Brief Research Article, Case Report, Clinical Trial, Community Case Study, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Registered Report, Review, Systematic Review, and many more.
Authors have the option of immediately submitting their work using the Submission link when submitting a manuscript to our Journal. Review and Associate Editors conduct peer reviews of manuscripts.
Journal of Neuroscience and Neuropharmacology articles have received high praise from eminent academics and professionals everywhere in the world. Journal of Neuroscience and Neuropharmacology has an h-index of 5, meaning that each article there has received an average of 5 citations.
Any papers that are made available for open access will always be free for everyone to read and download. The authors or the entity supporting the authors' research must pay the publishing fee (also known as the "Article Publishing Charge" or "APC") for each article published open access in this journal. This ensures that your post will be instantly and cost-free and available to everyone.
Since this is the largest publishing platform, when you publish open access with us, you get access to the elite experience of our editors and reviewers who quantify your impact and raise the exposure of your work.
Through the inclusion of your work in applicable databases and indexes, we ensure that it will always be discoverable and accessible.
With us, open-access publishing means that millions of academics across the world will have free access to your work.
Through a rigorous peer review process and affordable article publishing prices, our knowledgeable editors and reviewers ensure that all of our open-access publications maintain the highest standards of quality (APCs).
Neurodegenerative Diseases
Neurodegenerative diseases are chronic, incurable disorders that cause nerve cells to gradually deteriorate or even die. Ataxias, dementias, and other mobility and mental functioning issues result from this, which impairs a person's ability to move, speak, and breathe.
When nerve cells in the brain or peripheral nervous system start to lose their functionality over time and eventually die, this is known as a neurodegenerative illness. Although there are presently no known therapies for neurodegenerative disorders, certain treatments may be able to alleviate some of the physical or mental symptoms connected with these conditions.
With increasing age, a neurodegenerative illness is far more likely to occur. Given the rise in life expectancy, more Americans may develop neurodegenerative disorders in the ensuing decades. We must develop innovative methods for both therapy and prevention and better understand the factors that lead to neurodegenerative disorders.
Neurotoxicity
When the normal function of the nervous system is altered by exposure to harmful chemicals (neurotoxicants), this is known as neurotoxicity. As a result, neurons—important cells that send and process information in the brain and other areas of the nervous system—may eventually get damaged or even killed. In addition to heavy metals like lead and mercury, certain foods and food additives, pesticides, industrial and/or cleaning solvents, cosmetics, and some naturally occurring substances, neurotoxicity can be caused by exposure to substances used in chemotherapy, radiation therapy, drug therapies, and organ transplants.
The onset of symptoms following exposure might happen right away or later. They might include limb numbness or weakness; memory, vision, or intelligence loss; headache; cognitive and behavioral issues; and sexual dysfunction. Neurotoxicants may particularly affect people with specific diseases.
Parkinson's Disease
Parkinson's disease is a brain disorder that causes unintentional or uncontrolled movement including shaking, stiffness, and issues with balance and coordination.
Typically, symptoms begin lightly and worsen with time. As the condition progresses, people may experience difficulty speaking and moving. They could also display changed mental and behavioral habits, sleeping disorders, sadness, memory troubles, and tiredness.
Parkinson's disease symptoms manifest most obviously when nerve cells in the basal ganglia, an area of the brain that controls movement, are harmed or died. Dopamine is a crucial brain neurotransmitter that these nerve cells, or neurons, normally generate. Movement issues linked with the condition are a result of decreased dopamine production brought on by the neurons' degeneration or death. The reason why neurons die is still a mystery to scientists.
Norepinephrine, the primary chemical messenger of the sympathetic nervous system, which regulates numerous bodily processes including heart rate and blood pressure, is also lost in people with Parkinson's disease. The absence of norepinephrine may be the cause of several of Parkinson's disease's non-movement symptoms, including fatigue, erratic blood pressure, delayed digestion, and a sudden decrease in blood pressure after rising from a sitting or lying position.